+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Vitamin D Therapy Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4896131
  • Report
  • January 2020
  • Region: Global
  • 115 pages
  • Mordor Intelligence
UP TO OFF
until Jun 30th 2020
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Alkem Laboratories Ltd
  • Cadila Healthcare Ltd
  • GlaxoSmithKline PLC
  • Merck & Co Inc
  • Novartis AG
  • MORE
Market Overview

The Vitamin D Therapy Market studied was anticipated to grow with a CAGR of nearly 11.8% during the forecast period. The major factors attributing to the growth of the market are the presence of a huge patient pool due to lack of time with sedentary lifestyles along with the rapid growth of the aging population. Also, an increased prevalence of malnutrition cases such as osteoporosis and rickets among all the age groups in recent years has escalated the awareness programs and healthcare expenditure by the government authorities across the globe. For instance, according to the (CDC) Centers for Disease Control and Prevention report, in 2018, about USD 3.65 trillions of national health care expenditure was incurred by the United States which is expected to increase throughout the forecast period providing better opportunities to the research activities and manufacturers driving the global vitamin D therapy market.

Scope of the Report

Vitamin D is a group of fat-soluble secosteroids that are present only in few foods that are essential for the intestinal absorption of calcium, phosphate, and magnesium. When the skin is exposed to sunlight, it activates the synthesis of vitamin D from cholesterol. Among the vitamin D compounds, Vitamin D2 /ergocalciferol and vitamin D3 /cholecalciferol are considered to be essential for humans. The deficiency of these essential vitamins has been one of the most common problems in the past few years due to sedentary lifestyles leading to lesser exposure to sun resultant skin diseases, muscle weakness and bone pain driving the market.

Key Market Trends

Oral Route Of Administration is Expected to Hold the Major Market Share in the Vitamin D Therapy Market
  • The oral route of administration is expected to account for the largest share and highest CAGR over the forecast period. This dominance is owing to the ease of administration, safety, efficiency, reduced chances of toxicity coupled with patient compliance and preference for the oral route due to availability in various forms like chewing gums and tablets, driving the global market.
  • Based on purchasing patterns, the prescription drugs segment accounts for the largest share as the preference for the diagnosis by the registered medical practitioners and prescribed therapies with appropriate medications. Also, the higher cost of Prescribed medicines compared to OTC drugs is expected for the highest market revenue propelling the global vitamin D market.
  • On the basis of application, the osteoporosis segment is expected to register the highest growth during the forecast period due to the growth of aging population, rise in incidence of falls and fractures coupled with elevated levels of parathyroid hormones and the poor absorption of calcium from their diets which necessitates the Vitamin D therapy to enhance the calcium absorption.
North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the overall vitamin D therapy market throughout the forecast period. This dominance is mainly owing to the presence of leading players based in the United States, focus on research activities to develop more patient compliant products with enhanced efficiency coupled by the government support and increasing healthcare expenditure contributing to its outstanding market revenue share in the global vitamin D therapy market growth. Europe accounts for the second-largest share in the market which is attributed to its increased preference for the nutritional supplements due to enhanced healthcare awareness.

Regionally, the Asia Pacific market is anticipated to witness the highest CAGR in the overall vitamin D therapy market during the forecast period. The significant growth in the region can be attributed to sedentary lifestyles, huge target patient pool due to heavy population in developing nations like India, China and along with higher air pollution. Also, a rise in awareness programs about vitamin D deficiency by the government and manufacturers of emerging economies in the region is expected to boost the growth of the market propelling the global market revenue.

Competitive Landscape

The global Vitamin D therapy market is moderately competitive and consists of several major players. Some prominent players that are currently dominating the market In terms of market share are acquiring the products, entering into partnerships with the other companies to consolidate their market positions across the globe and while others are distributing products. For instance, in June 2018, GlaxoSmithKline completed the buyout of Novartis’ 36.5% stake in its Consumer Healthcare Joint Venture. Also, GSK completed a transaction with Pfizer in August 2019 to combine their consumer healthcare businesses and form a new world-leading Consumer Healthcare Joint Venture. The joint venture offers a range of products in vitamin and mineral supplements, among others which fuel the market growth. Some of the companies which are currently dominating the market are Pfizer Inc, Abbott Laboratories, GlaxoSmithKline PLC, Biotics Research Corporation, and Ortho Molecular Products Inc.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Alkem Laboratories Ltd
  • Cadila Healthcare Ltd
  • GlaxoSmithKline PLC
  • Merck & Co Inc
  • Novartis AG
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Huge Patient Pool with Sedentary Lifestyle and Rapidly Growing Aging Population
4.2.2 Rise in Awareness About Vitamin D Deficiency by the Government and Manufacturers
4.3 Market Restraints
4.3.1 Fortification of Foods
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Route of Administration
5.1.1 Oral
5.1.2 Parenteral
5.2 Purchasing Patterns
5.2.1 Prescription
5.2.2 Over-The-Counter
5.3 Application
5.3.1 Osteoporosis
5.3.2 Muscle Weakness
5.3.3 Autoimmune Disorders
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Ortho Molecular Products Inc
6.1.2 Biotics Research Corporation
6.1.3 GlaxoSmithKline PLC
6.1.4 Abbott Laboratories
6.1.5 Pfizer Inc
6.1.6 Novartis AG
6.1.7 Merck & Co Inc
6.1.8 Cadila Healthcare Ltd
6.1.9 Alkem Laboratories Ltd
6.1.10 Torrent Pharmaceuticals Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ortho Molecular Products Inc
  • Biotics Research Corporation
  • GlaxoSmithKline PLC
  • Abbott Laboratories
  • Pfizer Inc
  • Novartis AG
  • Merck & Co Inc
  • Cadila Healthcare Ltd
  • Alkem Laboratories Ltd
  • Torrent Pharmaceuticals Ltd
Note: Product cover images may vary from those shown
Adroll
adroll